Procrea Holdings,Inc. (7384) Price & Analysis

Compare

0 Followers

7384 Stock Chart & Stats

¥1704.00

-¥4.00(-0.23%)

At close: Jan 08 4:00 PM EST

¥1704.00

-¥4.00(-0.23%)

Day’s Range― - ―

52-Week Range¥1,303.00 - ¥2,953.00

Previous CloseN/A

Volume48.30K

Average Volume (3M)59.77K

Market Cap

¥79.99B

Enterprise Value¥599.18B

Total Cash (Recent Filing)¥0.00

Total Debt (Recent Filing)¥601.86B

Price to Earnings (P/E)1290.1

Beta0.90

Next Earnings

May 08, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.42%

Share Statistics

EPS (TTM)53.04

Shares Outstanding28,658,957

10 Day Avg. Volume54,130

30 Day Avg. Volume59,766

Financial Highlights & Ratios

PEG Ratio-0.70

Price to Book (P/B)0.31

Price to Sales (P/S)0.62

P/FCF Ratio0.23

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained top-line growth indicates recovering demand for Procrea's fertility products and services. Over a 2-6 month horizon this supports scale economies, improves unit margin prospects as volumes rise, and underpins reinvestment in R&D and clinic partnerships for durable market share gains.

Strong Cash ConversionNear-parity FCF to earnings and healthy operating cash conversion show the business turns accounting profits into real cash. That durable cash-generation ability funds capex and R&D, reduces reliance on external financing, and provides flexibility to support clinic partnerships and long-term product investment.

Specialized Fertility ModelA focused, specialized business model in reproductive health creates structural advantages: domain expertise, recurring procedure and consumable demand, and stickier clinic partnerships. This positioning supports differentiated product adoption and long-term revenue resilience in an aging/expanding fertility market.

Bears Say

Weak ProfitabilityVery low net margin and a negative EBIT margin point to structural cost or pricing pressures. Persistently weak operating profitability reduces retained earnings, limits funding for growth initiatives, and heightens sensitivity to revenue shocks over the medium term.

High LeverageA debt-to-equity ratio this high implies a thin equity buffer and sizable interest obligations. Over 2-6 months higher rates or a revenue slowdown could strain cash flow, limit strategic flexibility, and increase refinancing or covenant risks for capital-intensive clinic and device investments.

Earnings VolatilitySevere EPS contraction signals volatile or collapsing reported earnings, complicating planning and investor confidence. Persistent earnings instability undermines capacity to sustain dividends, attract long-term capital, and execute multi-year R&D or clinic expansion plans reliably.

Procrea Holdings,Inc. News

Procrea Flags Collection Risk on ¥2.15 Billion Loan Exposure but Keeps Earnings Outlook

Procrea Holdings,Inc. ( ($JP:7384) ) has issued an announcement. Procrea Holdings said its banking subsidiary Aomori Michinoku Bank...

7d ago

7384

Procrea Holdings Posts Higher Revenue but Lower Profit, Affirms Dividend and Strong Full-Year Outlook

An announcement from Procrea Holdings,Inc. ( ($JP:7384) ) is now available. Procrea Holdings reported consolidated results for the...

11d ago

7384

Procrea Holdings Reports Large Unrealized Bond Losses, Keeps Earnings Outlook Unchanged

Procrea Holdings,Inc. ( ($JP:7384) ) has shared an announcement. Procrea Holdings said its subsidiary Aomori Michinoku Bank booked...

20d ago

7384

Procrea Holdings to Merge Leasing Subsidiaries and Rebrand Group Units

Procrea Holdings,Inc. ( ($JP:7384) ) has provided an announcement. Procrea Holdings will merge its wholly owned leasing subsidiaries...

2M ago

7384

Procrea Holdings Reports Mixed Financial Results for H1 2025

An update from Procrea Holdings,Inc. ( ($JP:7384) ) is now available. Procrea Holdings, Inc. reported its consolidated financial...

3M ago

7384

Procrea Holdings Reports Unrealized Losses with No Impact on Financial Forecasts

Procrea Holdings,Inc. ( ($JP:7384) ) has issued an announcement. Procrea Holdings, Inc. announced unrealized losses of 8,271 million...

4M ago

7384

Procrea Holdings Reports Unrealized Losses on Securities

Procrea Holdings,Inc. ( ($JP:7384) ) has provided an update. Procrea Holdings, Inc. reported unrealized losses on securities held...

7M ago

7384

Procrea Holdings Revises Performance-Linked Remuneration Plan

Procrea Holdings,Inc. ( ($JP:7384) ) has issued an announcement. Procrea Holdings, Inc. announced the continuation and partial revision...

9M ago

7384

7384 FAQ

What was Procrea Holdings,Inc.’s price range in the past 12 months?

Procrea Holdings,Inc. lowest stock price was ¥1303.00 and its highest was ¥2953.00 in the past 12 months.

What is Procrea Holdings,Inc.’s market cap?

Procrea Holdings,Inc.’s market cap is ¥79.99B.

When is Procrea Holdings,Inc.’s upcoming earnings report date?

Procrea Holdings,Inc.’s upcoming earnings report date is May 08, 2026 which is in 80 days.

How were Procrea Holdings,Inc.’s earnings last quarter?

Procrea Holdings,Inc. released its earnings results on Feb 06, 2026. The company reported ¥53.036 earnings per share for the quarter, beating the consensus estimate of N/A by ¥53.036.

Is Procrea Holdings,Inc. overvalued?

According to Wall Street analysts Procrea Holdings,Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Procrea Holdings,Inc. pay dividends?

Procrea Holdings,Inc. pays a Semiannually dividend of ¥25 which represents an annual dividend yield of 2.42%. See more information on Procrea Holdings,Inc. dividends here

What is Procrea Holdings,Inc.’s EPS estimate?

Procrea Holdings,Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Procrea Holdings,Inc. have?

Procrea Holdings,Inc. has 28,658,957 shares outstanding.

What happened to Procrea Holdings,Inc.’s price movement after its last earnings report?

Procrea Holdings,Inc. reported an EPS of ¥53.036 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.657%.

Which hedge fund is a major shareholder of Procrea Holdings,Inc.?

Currently, no hedge funds are holding shares in JP:7384

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Procrea Holdings,Inc.

Procrea Holdings, Inc. (7384) is a leading company in the biotechnology sector, specializing in reproductive health and fertility solutions. The company focuses on developing and providing innovative products and services that enhance reproductive outcomes, including advanced assisted reproductive technologies, fertility preservation methods, and related medical devices. Procrea Holdings aims to support individuals and families in their journey to parenthood through its comprehensive suite of offerings in reproductive medicine.